ArticleThe Journal of clinical investigation2026
Targeting casein kinase 1α-mediated FADD phosphorylation restores sensitivity in select CDK4/6 inhibitor-resistant breast cancer models.
Sahezeel Awadia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.